K231081: Dexcom G7 Continuous Glucose Monitoring (CGM) System (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K231081 (Dexcom G7 Continuous Glucose Monitoring (CGM) System, cleared 2023-05-15 for Dexcom, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K231081
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK231081
Cleared Device Trade / Generic NameDexcom G7 Continuous Glucose Monitoring (CGM) System
FDA Applicant on FilingDexcom, Inc.
FDA 3-Letter Product ClassificationProduct Code QBJ
FDA Substantial Equivalence Decision Date2023-05-15
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Dexcom across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Dexcom, Inc., compare peer devices under FDA Product Code QBJ, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.